EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Tertiary lymphoid structures and their therapeutic implications in cancer

Xun Chen, Pan Wu, Ziqi Liu, Tiansheng Li, Jie Wu, Zhaoyang Zeng, Wenjia Guo, Wei Xiong

Cellular Oncology · 2024

DOI: 10.1007/s13402-024-00975-1 ↗

At a glance

Übersichtsarbeit in Cellular Oncology, 2024. Written by Xun Chen and 7 co-authors. Institution: NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiang…. Major MEDLINE topics: Tertiary Lymphoid Structures, Neoplasms, Immunotherapy. Cited 12 times so far (Crossref); 107 references. The full text is freely available in PubMed Central. Funded by: Natural Science Foundation of Hunan Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates formed by the structured accumulation of immune cells such as B cells and T cells in non-lymphoid tissues induced by infection, inflammation, and tumors. They play a crucial role in the immune response, particularly in association with tumor development, where they primarily exert anti-tumor immune functions during tumorigenesis. Current research suggests that TLSs inhibit tumor growth by facilitating immune cell infiltration and are correlated with favorable prognosis in various solid tumors, serving as an indicator of immunotherapy effectiveness to some extent. Therefore, TLSs hold great promise as a valuable biomarker. Most importantly, immunotherapies aimed to prompting TLSs formation are anticipated to be potent adjuncts to current cancer treatment. This review focuses on the formation process of TLSs and their potential applications in cancer therapy.

Subjects

MeSH terms (MEDLINE)

Tertiary Lymphoid StructuresNeoplasmsImmunotherapyHumansAnimalsTumor Microenvironment

Author keywords

BiomarkerCancer therapyImmune responsePrognosisTertiary lymphoid structures

Authors and institutions

  • NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China.
  • Departments of Cancer Research Institute, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
  • Xinjiang Key Laboratory of Translational Biomedical Engineering, Urumqi, China.
  • Departments of Cancer Research Institute, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China. wenjiaguo@xjmu.edu.cn.
  • Xinjiang Key Laboratory of Translational Biomedical Engineering, Urumqi, China. wenjiaguo@xjmu.edu.cn.

Funding

  • Natural Science Foundation of Hunan Province

Cite

APA

Chen, X., Wu, P., Liu, Z., Li, T., Wu, J., Zeng, Z., Guo, W., & Xiong, W. (2024). Tertiary lymphoid structures and their therapeutic implications in cancer. Cellular Oncology. https://doi.org/10.1007/s13402-024-00975-1

Vancouver

Chen X, Wu P, Liu Z, Li T, Wu J, Zeng Z, et al. Tertiary lymphoid structures and their therapeutic implications in cancer. Cellular Oncology. 2024. doi:10.1007/s13402-024-00975-1

BibTeX
@article{Chen2024,
  author = {Chen, Xun and Wu, Pan and Liu, Ziqi and Li, Tiansheng and Wu, Jie and Zeng, Zhaoyang and Guo, Wenjia and Xiong, Wei},
  title = {Tertiary lymphoid structures and their therapeutic implications in cancer},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-024-00975-1}
}
Start for free →